Cordant, Secon Settle Unnecessary Drug Test Claims With Feds

Cordant Health Solutions and its subsidiary Secon Laboratories paid $845,108 to resolve allegations they violated the federal and Connecticut False Claims Acts for knowingly providing medically unnecessary drug tests used by a behavioral health residential treatment center, the U.S. Attorney’s Office for the District of Connecticut said Friday.

The government said Cordant knew or should have known the tests ordered by Crossroads Inc. for its residents more than twice a week weren’t required, the announcement said.

The federal government and Connecticut asserted that Cordant failed to report and return overpayments for claims Connecticut Medicaid paid Cordant for performing the ...